CDKN1A and sarcoma: Furthermore, we measured the expression level of these genes in two sarcoma cell lines with modified MAP17 expression, previously described in our laboratory.50 Ectopically increased MAP17 expression (in AA cell line), modified CCNB1 mRNA levels with a significant decrease, while BTG2 and CDKN1A mRNA levels increased.